Effectiveness of second-line treatment in AL amyloidosis patient's refractory to M-Dex

Amyloid. 2011 Jun:18 Suppl 1:145-7. doi: 10.3109/13506129.2011.574354054.
No abstract available

Publication types

  • Multicenter Study
  • Randomized Controlled Trial

MeSH terms

  • Administration, Oral
  • Amyloidosis / drug therapy*
  • Amyloidosis / immunology
  • Dexamethasone / administration & dosage
  • Dexamethasone / therapeutic use*
  • Drug Therapy, Combination
  • Humans
  • Immunoglobulin Light Chains*
  • Melphalan / administration & dosage
  • Melphalan / therapeutic use*
  • Recurrence
  • Retrospective Studies

Substances

  • Immunoglobulin Light Chains
  • Dexamethasone
  • Melphalan